Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Alaunos Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 125 | 1 | 125 | +1 |
| Shares | 73.4M | 15.0K | 74.7M | +1.36M (+1.8%) |
| Value | $90.7M | $19.0K | $128.6M | +$37.9M (+41.7%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boxer Capital, LLC | 1,500,000 | $2.58M | 0.15% |
| EAM Investors, LLC | 454,625 | $782.0K | 0.17% |
| Rafferty Asset Management, LLC | 220,543 | $379.0K | 0.00% |
| Barclays PLC | 136,136 | $234.0K | 0.00% |
| Virtu Financial LLC | 74,592 | $128.0K | 0.01% |
| Silverlake Wealth Management LLC | 56,993 | $98.0K | 0.07% |
| Occudo Quantitative Strategies LP | 52,635 | $91.0K | 0.01% |
| Two Sigma Securities, LLC | 51,345 | $88.0K | 0.01% |
| Belvedere Trading LLC | 66,493 | $78.0K | 0.09% |
| Zacks Investment Management | 44,550 | $77.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 42,441 | $73.0K | 0.00% |
| Concorde Asset Management, LLC | 35,500 | $61.0K | 0.07% |
| XTX Topco Ltd | 23,724 | $41.0K | 0.01% |
| SevenBridge Financial Group, LLC | 20,000 | $34.0K | 0.01% |
| E Fund Management Co., Ltd. | 15,167 | $26.0K | 0.00% |
| National Asset Management, Inc. | 11,557 | $20.0K | 0.00% |
| Cutler Group LP | 4,097 | $7.00K | 0.00% |
| Parallax Volatility Advisers, L.P. | 1,975 | $3.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 2,024 | $3.00K | 0.00% |
| Tucker Asset Management LLC | 200 | $230 | 0.00% |
Sold out (19)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Millennium Management LLC | 2,169,705 | $2.69M |
| Point72 Asset Management, L.P. | 1,000,000 | $1.24M |
| D. E. Shaw & Co., Inc. | 186,601 | $231.0K |
| Jane Street Group, LLC | 111,647 | $138.0K |
| Boothbay Fund Management, LLC | 34,091 | $42.0K |
| Teacher Retirement System of Texas | 32,388 | $40.0K |
| Balyasny Asset Management LLC | 30,759 | $38.0K |
| Pathway Financial Advisors LLC | 31,000 | $38.0K |
| Y-Intercept (Hong Kong) Ltd | 25,079 | $31.0K |
| Cambridge Investment Research Advisors, Inc. | 14,275 | $18.0K |
| Pinz Capital Management, LP | 10,900 | $14.0K |
| Captrust Financial Advisors | 6,750 | $8.00K |
| Aquatic Capital Management LLC | 2,600 | $3.00K |
| Charter Oak Capital Management, LLC | 2,500 | $3.00K |
| New York State Common Retirement Fund | 1,650 | $2.00K |
| The PNC Financial Services Group, Inc. | 258 | $0 |
| Credit Suisse AG | 12 | $0 |
| ACG Wealth | 162 | $0 |
| Geneos Wealth Management Inc. | 491 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Altium Wealth Management LLC | 15,000 | $19.0K |